Clinical Review

A reasoned plan to manage a persistent Category-II FHR tracing

Author and Disclosure Information

When intrapartum fetal heart-rate monitoring reveals a persistent
Category-II tracing, you don’t have to linger in limbo—you can respond
in a systematic way


 

References

RELATED ARTICLES

CASE An uncertain interlude during labor

An obstetrician checks on her laboring patient, only to discover that the fetal heart-rate (FHR) tracing has moved from Category I, a normal classification, into Category II—a gray zone. The OB decides to be proactive, not simply to wait for the tracing to return to normal. She has the patient move from a supine to a lateral position, provides oxygen, and administers a bolus of 500 to 1,000 mL of lactated Ringer’s solution over 20 minutes.

The tracing remains in Category II.

What should the OB do next?


When a fetal heart-rate tracing remains in Category II despite well-considered conservative corrective measures, a reasoned, rather than passive, approach is recommended.In 2008, the National Institute of Child Health and Human Development proposed a three-tier classification system for electronic FHR tracings (TABLE 1).1 Tracings in Category I are considered normal and can be managed routinely.1-3 Category-III tracings are considered abnormal and require additional attention; if corrective measures do not result in improvement, rapid delivery usually is warranted.1-3 Category II includes all FHR tracings that do not fit into either of the other categories. Because Category II encompasses such a wide range of FHR tracings, there are many options for management.

TABLE 1

3-tier fetal heart-rate classification system

CategoryDescription
IFetal heart-rate (FHR) tracings include all of the following:
  • baseline rate is 110–160 bpm
  • baseline FHR variability is moderate
  • accelerations are present or absent
  • late or variable decelerations are absent
  • early decelerations are present or absent
IIIncludes all FHR tracings not included in Category I or Category III
IIIFHR tracings include:
  • absent baseline FHR variability plus:
  • sinusoidal pattern
Source: Adapted from Macones GA, et al.1

If the case described above sounds familiar, it may be that you read Editor in Chief Dr. Robert L. Barbieri’s editorial on Category-II FHR tracings in the April 2011 issue of OBG Management.4 That essay described a number of common conservative corrective measures applicable for Category-II tracings, including the three interventions the OB performed.

Other measures:

  • reduce or stop infusion of oxytocin
  • discontinue cervical ripening agents
  • consider administering a tocolytic, such as terbutaline, if tachysystole is present or if uterine contractions are prolonged or coupled
  • consider the option of amnioinfusion if variable decelerations are present.4,5

Systematic review of the oxygen pathway, from the environment to the fetus (maternal lungs, heart, vasculature, uterus, placenta, and umbilical cord), can facilitate recollection of all of these measures. In addition, a simplified “A-B-C-D” approach to the management of a Category-II FHR tracing is helpful (TABLES 2 and 3):

  1. Assess the oxygen pathway
  2. Begin conservative corrective measures
  3. Clear obstacles to rapid delivery
  4. Determine decision-to-delivery time.6,7

TABLE 2

Conservative corrective measures to improve fetal oxygenation

“A”
Assess oxygen pathway
“B”
Begin corrective measures if indicated
LungsAirway and breathingSupplemental oxygen (10 L) using a tight-fitting, non-rebreather face mask for at least 15 minutes
HeartHeart rate and rhythmPosition changes IV fluid bolus (500–1,000 cc of isotonic fluid over 20 min) Correct hypotension
VasculatureBlood pressure Volume status
UterusContraction strength Contraction frequency Baseline uterine tone Exclude uterine ruptureStop or reduce uterine stimulants (oxytocin, prostaglandin) Consider uterine relaxant (terbutaline)
PlacentaPlacental separation Bleeding vasa previa
CordVaginal exam Exclude cord prolapseConsider amnioinfusion
Courtesy of David A. Miller, MD

As the obstetrician in the opening scenario knows all too well, conservative corrective measures do not always transform FHR tracings from Category II to Category I. In fact, it is extremely common for a Category-II tracing to remain in Category II despite every conservative corrective measure in the book. This article presents a practical, systematic, standardized approach to the management of a persistent Category-II FHR tracing.

TABLE 3

Steps involved in preparing for delivery

“C”
Clear obstacles to rapid delivery
“D”
Determine decision-to-delivery time
FacilityOperating room availability EquipmentFacility response time
StaffNotify:   Obstetrician   Surgical assistant   Anesthesiologist   Neonatologist   Pediatrician   Nursing staffConsider staff:   Availability   Training   Experience
MotherInformed consent Anesthesia options Laboratory tests Blood products Intravenous access Urinary catheter Abdominal prep Transfer to ORSurgical considerations   (prior abdominal or uterine surgery) Medical considerations   (obesity, hypertension, diabetes, SLE) Obstetric considerations   (parity, pelvimetry, placental location)
FetusConfirm:   Estimated fetal weight   Gestational age   Presentation   PositionConsider factors such as:   Estimated fetal weight   Gestational age   Presentation   Position
LaborConfirm adequate monitoring of uterine contractionsConsider factors such as:   Arrest disorder   Protracted labor   Remote from delivery   Poor expulsive efforts
Courtesy of David A. Miller, MD

CASE Continued

When the OB’s preliminary interventions fail to nudge the FHR tracing back to Category I, she stops oxytocin and administers terbutaline. She even tries amnioinfusion. Still, the FHR tracing remains in Category II.

Pages

Recommended Reading

Itchy and Pregnant? Consider Range of Causes
MDedge ObGyn
Proposed Gestational Diabetes Criteria Raise Questions, Concerns
MDedge ObGyn
Ob/Gyn Hospitalists Hold Inaugural Meeting
MDedge ObGyn
Gestational Diabetes, BMI Over 25 Raise Cardiac Risk
MDedge ObGyn
DES Exposure Elevates Risk of 12 Adverse Outcomes
MDedge ObGyn
Pre-Pregnancy Diet Linked to Birth Defects
MDedge ObGyn
Noninvasive test identifies more than 98% of Down syndrome cases
MDedge ObGyn
What is the optimal interval between administration of antenatal corticosteroids and preterm delivery?
MDedge ObGyn
New data: Foley catheter is as effective as prostaglandin gel for induction of labor—with fewer side effects
MDedge ObGyn
10 practical, evidence-based recommendations to improve outcomes in women who have eclampsia
MDedge ObGyn